Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. My name is Tawanda, and I will be your operator for today's call.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 500,230 | $356,328,836 | +88% | 0.26% |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 254,579 | $181,344,259 | 0.17% | |
| 3. | Renaissance Technologies Jim Simons | 247,743 | $176,474,771 | +18% | 0.26% |
| 4. | 207,300 | $147,666,009 | +4% | 0.02% | |
| 5. | AQR Capital Management Cliff Asness | 207,085 | $147,096,307 | -9% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | 23,880,537 | 2017-08-25 | Filing | ||
| $485.99 | 2,681 | 23,877,980 | 2017-08-25 | Filing | ||
| $485.28 | 5,723 | 23,875,299 | 2017-08-25 | Filing | ||
| $484.21 | 2,000 | 23,869,576 | 2017-08-25 | Filing | ||
| $482.87 | 4,485 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $844.61 | 1,000 | Officer | 12,931 | 2024-11-01 | Filing | |
| $1,059.28 | 2 | Director | 17,582 | 2024-10-01 | Filing | |
| $1,057.38 | 2 | Director | 17,584 | 2024-10-01 | Filing | |
| $1,056.68 | 3 | Director | 17,586 | 2024-10-01 | Filing | |
| $1,054.90 | 3 | Director | 17,589 | 2024-10-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,286,346 | $6,614,942,845 | 0.11% | |
| 2. | 8,731,622 | $6,219,796,349 | 0.12% | |
| 3. | 8,199,579 | $5,840,806,944 | 0.34% | |
| 4. | 7,059,371 | $5,028,602,870 | 0.37% | |
| 5. | 4,832,239 | $3,441,859,354 | 0.13% |
News See All
10 Best Cancer Stocks to Buy According to Hedge Funds
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
12 Best S&P 500 Stocks to Invest in According to Analysts
2024 was a memorable year for the broad market index, which posted a gain of 23.31%, building on the 24.2% return in 2023.
12 Best Depressed Stocks to Invest in Now
The US stocks ended 2024 with a healthy Q4, as the equity markets were primarily aided by solid economic growth, healthy earnings momentum, and the expectations of the rate cuts.
10 Best Stocks to Buy and Hold For 2025
Stocks have been performing well lately as they seem to have been influenced by the excitement around artificial intelligence (AI) as well as the new administration.
10 Best Falling Stocks to Invest in Right Now
The overall stock market has been in an uptrend, as depicted by major indices trading near all-time highs.
9 Stocks on Jim Cramer’s Radar
Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus on the growth prospects of certain pharmaceutical stocks while also answering callers...
Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks
In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release.
Jim Cramer's Bold Predictions About These 10 Healthcare Stocks
Healthcare has been one of Jim Cramer's favorite topics lately.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Billionaire Hedge Funds
